Orthotopic heart transplantation for congenital heart defects: situs inversus

Author(s):  
O. Raisky ◽  
D. Tamisier ◽  
P. R. Vouhe
1987 ◽  
Vol 28 (1) ◽  
pp. 227-228 ◽  
Author(s):  
Andrew Czeizel ◽  
John M. Opitz ◽  
James F. Reynolds

2015 ◽  
Vol 156 (3) ◽  
pp. 92-97
Author(s):  
István Hartyánszky ◽  
Sándor Varga ◽  
Kálmán Havasi ◽  
Barna Babik ◽  
Márta Katona ◽  
...  

Due to improving results in congenital heart surgery, the number of adult patients with congenital heart defect is increasing. The question is: what kind of problems can be managed in this patient-group? The authors review the different problems of management of congenital heart defects in adults based on national and international literature data. Simple defects recognised in adults, postoperative residual problems, changing of small grafts and valves, correction of primary or operated coarctation aortae can be usually managed without problems. A very close follow-up is necessary to establish the correct period for heart transplantation in patients with transposition of great arteries with Senning/Mustard operation, and univentricular heart corrected with “Fontan-circulation” type surgical procedure. The authors conclude that although the number of patients increases, only a few congenital heart diseases may cause problems. It seems important (1) to monitor asymptomatic patient who underwent operation (Fallot-IV, Ross procedure, etc.), (2) follow up regularly patients who underwent Senning/Mustard procedure (magnetic resonance imaging, echocardiography, brain natriuretic peptide measurement), (3) define the proper period of preparation for heart transplantation of patients with a univentricular heart, with special attention to the possibility of multiorgan (lung, liver, etc.) failure. Due to the improvement of foetal diagnosis of congenital heart defects, the number of patients with complex congenital heart defects is decreasing. The standard management of these patients could be primary heart transplantation in infancy. Orv. Hetil., 2015, 156(3), 92–97.


1988 ◽  
Vol 31 (3) ◽  
pp. 689-690 ◽  
Author(s):  
Al Calabro ◽  
A. Taraschi ◽  
M. S. Lungarotti ◽  
A. Ferdinandi ◽  
John M. Opitz ◽  
...  

2022 ◽  
Vol 4 (1) ◽  
pp. 01-02
Author(s):  
Hakan Gokalp TAS ◽  
Hüsnü Degirmenci

For operations including coronary artery by-pass grafting (CABG), heart valve repair or replacement, ascending aorta surgeries, heart transplantation, and surgical correction of congenital heart defects, anesthesia management shares many similar concepts


1987 ◽  
Vol 26 (1) ◽  
pp. 181-184 ◽  
Author(s):  
J. Zlotogora ◽  
M. S. Schimmel ◽  
Y. Glaser ◽  
James F. Reynolds

2021 ◽  
Vol 8 ◽  
Author(s):  
Jennie H. Kwon ◽  
Morgan Ashley Hill ◽  
Brielle Gerry ◽  
Jordan Morningstar ◽  
Minoo N. Kavarana ◽  
...  

Congenital heart defects are the most common types of birth defects in humans. Children with congenital heart defects frequently require heart valve replacement with an implant. Unfortunately, conventional heart valve implants do not grow. Therefore, these children are committed to serial re-operations for successively larger implant exchanges. Partial heart transplantation is a new and innovative approach to deliver growing heart valve implants. However, the transplant biology of partial heart transplant grafts remains unexplored. This is a critical barrier for clinical translation. Therefore, we investigated the cellular viability of partial heart transplants in cold storage. Histology and immunohistochemistry revealed no morphological differences in heart valves after 6, 24, or 48 h of cold storage. Moreover, immunohistochemistry showed that the marker for apoptosis activated caspase 3 and the marker for cell division Ki67 remained unchanged after 48 h of cold storage. Finally, quantification of fluorescing resorufin showed no statistically significant decrease in cellular metabolic activity in heart valves after 48 h of cold storage. We conclude that partial heart transplants remain viable after 48 h of cold storage. These findings represent the first step toward translating partial heart transplantation from the bench to the bedside because they have direct clinical implications for the procurement logistics of this new type of transplant.


Sign in / Sign up

Export Citation Format

Share Document